CN108059308A - A kind of clindamycin wastewater preprocessing process - Google Patents
A kind of clindamycin wastewater preprocessing process Download PDFInfo
- Publication number
- CN108059308A CN108059308A CN201711460314.XA CN201711460314A CN108059308A CN 108059308 A CN108059308 A CN 108059308A CN 201711460314 A CN201711460314 A CN 201711460314A CN 108059308 A CN108059308 A CN 108059308A
- Authority
- CN
- China
- Prior art keywords
- clindamycin
- waste water
- preprocessing process
- dosage
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F9/00—Multistage treatment of water, waste water or sewage
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/24—Treatment of water, waste water, or sewage by flotation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/5236—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using inorganic agents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/54—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
- C02F1/56—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F2001/007—Processes including a sedimentation step
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/105—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/12—Halogens or halogen-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/34—Nature of the water, waste water, sewage or sludge to be treated from industrial activities not provided for in groups C02F2103/12 - C02F2103/32
- C02F2103/343—Nature of the water, waste water, sewage or sludge to be treated from industrial activities not provided for in groups C02F2103/12 - C02F2103/32 from the pharmaceutical industry, e.g. containing antibiotics
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/08—Chemical Oxygen Demand [COD]; Biological Oxygen Demand [BOD]
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/02—Aerobic processes
- C02F3/10—Packings; Fillings; Grids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Abstract
The invention discloses a kind of clindamycin wastewater preprocessing process, step is as follows:(1)Clindamycin waste water enters high-efficient shallow air flotation device, and suspended matter therein is removed through agent-feeding treatment;(2)Sewage after air-flotation process enters new sludge reduction multi stage decompression system(Modified Contact Oxidation Process), carrying out biochemical treatment reduces organic concentration in waste water;(3)The further advanced treating of water outlet after biochemical treatment, using the method for Fenton oxidation after first coagulation so that treated, and water outlet COD is down to 50 below mg/L.Organic matter after this process in waste water substantially reduces, and multiple-effect evaporation can be avoided to extract salt timesharing, and organic matter is fixedly arranged at salinity surface and forms colloid substance;The difficulty of extraction salinity is reduced, salinity purity is improved, is conducive to recycle.
Description
Technical field
The invention belongs to environmental technology fields, and in particular to a kind of clindamycin wastewater preprocessing process.
Background technology
Clindamycin is a kind of antibiotic that Lincomycin Hydrochloride is chemically synthesized, and clindamycin waste water belongs to antibiotic
Class waste water is generated by the laggard one-step synthesis of microbial fermentation.It is generated during chemical synthesis containing sodium chloride, sodium phosphate
High-salt wastewater, main component NaCl, Na3PO4Deng, and COD concentration is higher in waste water.
The technique of domestic processing clindamycin waste water is mainly multiple-effect evaporation and biochemistry combination process at present, is to handle at present
It the characteristics of proper method of organic wastewater with difficult degradation thereby with high salt, multiple-effect evaporation is reduced with pressure using the boiling point of water and reduced, will be useless
Salinity in water is separated, and then the organic matter in waste water is efficiently removed by biochemical method.But multiple-effect evaporation method is dense
The solid salinity obtained after contracting can not be comprehensively utilized due to containing large amount of organic, form dangerous solid waste.
The content of the invention
For problems of the prior art, the present invention provides the pretreatment before a kind of clindamycin waste water is concentrated by evaporation
Technique, the organic matter after this process in waste water substantially reduce, and multiple-effect evaporation can be avoided to extract salt timesharing, organic matter consolidation
Colloid substance is formed on salinity surface;The difficulty of extraction salinity is reduced, salinity purity is improved, is conducive to recycle;Flow letter
Single, operating cost is low, and management is convenient.
The technical solution adopted by the present invention to solve the technical problems is:
(1)Air-flotation process:Clindamycin waste water enters high-efficient shallow air flotation device, by controlling dosage, removes therein outstanding
Float is without causing phosphate to form precipitation;Added drug is aluminium polychloride and polyacrylamide;The dosing of aluminium polychloride
It measures as 0.2-0.5 g/L, polyacrylamide uses cationic, and dosage is 2.0-5.0 mg/L;In such dosage item
Under part, suspended matter all removes, and phosphate not yet generates precipitation with the reactive aluminum in aluminium polychloride;
High-efficient shallow air flotation integrates cohesion, air supporting, skimming, precipitates, scrapes mud, is used on the basis of traditional air supporting theory
" shallow pool theory " and " zero-speed " principle is designed, and floor space is smaller, processing capacity is strong, and treatment effeciency is high, and it is shallow to surpass effect
Layer air supporting can effectively remove COD and suspended material in waste water;
(2)Biochemical treatment:Sewage after air-flotation process enters MCOP(Modified Contact Oxidation Process)
System carries out biochemical treatment under high salt conditions, and the organic concentration in sewage is greatly reduced, hydrophobicity is added in MCOP systems
Filler, the additive amount of filler is 2-4 kg/m3, MCOP systems are multi-stage aerobic aeration system, can form complete biological chain, make
Microorganism realizes degradation to organic matter under high salt conditions.
MCOP systems are multi-stage aerobic aeration system, and waste water fluidised form is pulling flow type, and hydraulic detention time is 3-4 d, MCOP
System adds in bio-carrier, and bio-carrier uses hydrophobicity flexible filler made of nylon 6, not easily to fall off, will not cause equipment
Blocking and damage, the big aeration in aperture is good, and filling rate is high, does not block wall structure, increases specific surface area, is easy to microorganism
Attachment;The microorganism in each aerating system is caused orderly to develop by the way of multi-stage aeration, it is complete raw to be formed
Object chain due to adding for filler, has higher sludge concentration in system, since sludge age is longer, sludge yield is low, dirty
Mud is reduced 50%-60%.
(3)Advanced treating:Water outlet after biochemical treatment carries out advanced treating, is aoxidized using Fenten after first coagulating sedimentation
Method;Coagulated agent uses bodied ferric sulfate and polypropylene milling amine, and the dosage of bodied ferric sulfate is 0.2-0.6 g/L, and poly- third
Acrylamide uses cationic, dosage 0.5-1.0mg/L;The dosage of Fenton oxidation is:FeSO4·7H20 is 0.6-
1.0 g/L;H2O2(Mass fraction is 30%)For 1.4-2.0 mL/L, polyacrylamide uses cationic, dosage 1.0-
1.2 mg/L, the organic matter of difficult for biological degradation is aoxidized in waste water so that treated, and water outlet COD is down to 50 below mg/L, has
Multiple-effect evaporation processing is carried out beneficial to follow-up waste water.
Beneficial effects of the present invention:Pretreating process before the clindamycin waste water evaporation and concentration of the present invention, can make micro-
Biology still maintains certain activity under high salt conditions, has higher organic removal rate;Can substantially reduce in waste water has
Machine object content so that organic object is practically free of in the salt-mixture that multiple-effect evaporation technique is extracted, the separation for being conducive to salt-mixture carries
It is pure;Meanwhile this technological process is simple, operating cost is low, and management is convenient.Pretreatment of the present invention as multiple-effect evaporation technique, energy
Enough remove the organic matter in waste water so that organic object is practically free of in the salt-mixture that multiple-effect evaporation technique is extracted, is conducive to mix
Close the separating-purifying of salt.
Description of the drawings
Fig. 1 is the attached clindamycin wastewater preprocessing process flow chart of the present invention.
Specific embodiment
With reference to specific embodiment, the present invention will be further described.It is to be understood that following embodiment is merely to illustrate this
The scope of invention and is not intended to limit the present invention, the person skilled in the art in the field can make one according to the content of foregoing invention
A little nonessential modifications and adaptations.
A kind of clindamycin wastewater preprocessing process of 1 couple of present invention makees following detailed description of referring to the drawings.
Pending clindamycin waste water quality is as follows:COD 12000mg/L, salinity 4.5%, TP 2000 mg/L, TN
300 mg/L of 800 mg/L, SS.
Clindamycin waste water is pre-processed by following steps:
(1)Clindamycin waste water enters high-efficient shallow air flotation device, and aluminium polychloride is added in flotation tank(PAC)With a small amount of poly- third
Acrylamide(PAM), remove suspended material therein, the dosage of aluminium polychloride is 0.3 g/L, polyacrylamide using sun from
Subtype, dosage are 2.5 mg/L, and after processing, 85 mg/L of water outlet SS, removal rate is up to 71.7%;
(2)Waste water after air-flotation process enters MCOP systems and carries out biological treatment, and microorganism is greatly reduced under high salt conditions
Organic concentration in waste water, after the processing of MOCP systems, COD is down to 900mg/L, removal rate 92%;
(3)By the further advanced treating of water outlet after biochemical treatment, using the method for Fenton oxidation after first coagulating sedimentation;Coagulation
Medicament uses bodied ferric sulfate and polyacrylamide, and the dosage of bodied ferric sulfate is 0.4 g/L, polyacrylamide using sun from
Subtype, dosage are 0.3 mg/L, and coagulation water outlet COD is 400mg/L, and removal rate is up to 55%;The dosage of Fenton oxidation is:
FeSO4·7H20 is 0.8 g/L;H2O2(Mass fraction 30%)For 1.6 mL/L, polyacrylamide uses cationic, dosage
For 1 mg/L;Fenton oxidation water outlet COD is conducive to follow-up waste water and carries out multiple-effect evaporation processing in below 50mg/L.
It is enterprise's long term monitoring data below:
Enterprise for a long time detection statistics indicate that, using the method for the present invention, organic removal rate can reach 99%, and the removal rate of total phosphorus is only
For 10%, most phosphate is remained while organics removal, which can be in follow-up multiple-effect evaporation technique
It is extracted, realizes the maximization of the utilization of resources.
Illustrative embodiments listed above are only for understanding that the present invention is used, not to technical solution described in the invention
It limits, the general technical staff in relation to field on the basis of technical solution described in claim, can also make a variety of variations
Or deformation, all equivalent variations or deformation should all be covered within the protective scope of the claims of the present invention.The present invention is not
Part is described in detail, is the known technology of those skilled in the art of the present technique.
Claims (8)
1. a kind of clindamycin wastewater preprocessing process, it is characterised in that step is as follows:
(1)Air-flotation process:Clindamycin waste water enters high-efficient shallow air flotation device, through agent-feeding treatment, removes suspended matter therein;
(2)Biochemical treatment:Sewage after air-flotation process enters MCOP systems, and biochemical treatment is carried out under high salt conditions;
(3)Advanced treating:Water outlet after biochemical treatment carries out advanced treating, the side aoxidized using Fenten after first coagulating sedimentation
Method so that treated, and water outlet COD is down to 50 below mg/L, is conducive to follow-up waste water and carries out multiple-effect evaporation processing.
2. clindamycin wastewater preprocessing process according to claim 1, it is characterised in that:The step(1)Using super
Imitate the suspended matter in shallow air-floatation device removal waste water, added drug is aluminium polychloride and polyacrylamide, the polypropylene
Amide uses cationic-type polyacrylamide.
3. clindamycin wastewater preprocessing process according to claim 2, it is characterised in that:The aluminium polychloride adds
Dose is 0.2-0.5 g/L, and the dosage of cationic-type polyacrylamide is 2.0-5.0mg/L.
4. clindamycin wastewater preprocessing process according to claim 1, it is characterised in that:The step(2)MCOP systems
The hydrophobic filler added in system, the additive amount of hydrophobic filler is 2-4 kg/m3。
5. clindamycin wastewater preprocessing process according to claim 4, it is characterised in that:The hydrophobic filler uses
Nylon 6 is made.
6. clindamycin wastewater preprocessing process according to claim 1, it is characterised in that:The step(2)Using
MCOP systems are multi-stage aerobic aeration system, can form complete biological chain, retention time of sewage 3-4d so that microorganism exists
The degradation to organic matter is realized under high salt conditions.
7. clindamycin wastewater preprocessing process according to claim 1, it is characterised in that:The step(3)Coagulation sinks
Coagulated agent during shallow lake uses bodied ferric sulfate and cationic polypropylene milling amine, wherein, the dosage of bodied ferric sulfate is
0.2-0.6 g/L, the dosage of cationic-type polyacrylamide is 0.5-1.0mg/L.
8. clindamycin wastewater preprocessing process according to claim 1, it is characterised in that:The step(3)Fenton
FeSO during oxidation4·7H20 dosage is 0.6-1.0 g/L, and mass fraction is 30% H2O2Dosage be 1.4-2.0
ML/L, the dosage of cationic-type polyacrylamide is 1.0-1.2 mg/L.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711460314.XA CN108059308B (en) | 2017-12-28 | 2017-12-28 | Chloramphenicol wastewater pretreatment process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711460314.XA CN108059308B (en) | 2017-12-28 | 2017-12-28 | Chloramphenicol wastewater pretreatment process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108059308A true CN108059308A (en) | 2018-05-22 |
CN108059308B CN108059308B (en) | 2021-04-02 |
Family
ID=62140599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711460314.XA Active CN108059308B (en) | 2017-12-28 | 2017-12-28 | Chloramphenicol wastewater pretreatment process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108059308B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109534477A (en) * | 2018-11-30 | 2019-03-29 | 华南师范大学 | A kind of biodegrading process of lincomycin |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102351377A (en) * | 2011-07-08 | 2012-02-15 | 郑州大学 | Integrated treatment method for fermentation pharmaceutical wastewater |
CN102826710A (en) * | 2012-08-17 | 2012-12-19 | 北京交通大学 | Treatment process and treatment device of high-salinity high-ammonia nitrogen pharmaceutical sewage |
CN104556528A (en) * | 2013-10-11 | 2015-04-29 | 郑州大学 | An integrated treatment process of clindamycin alkaline wastewater |
CN105036486A (en) * | 2015-08-17 | 2015-11-11 | 台州学院 | Method for deeply treating antibiotic pharmaceutical wastewater based on magnetic Fenton-like resin |
CN105417888A (en) * | 2015-12-18 | 2016-03-23 | 郑州大学综合设计研究院有限公司 | Clindamycin hydrochloride waste water processing technology |
CN106348545A (en) * | 2016-11-08 | 2017-01-25 | 河南君和环保科技有限公司 | Integrated treatment process for clindamycin hydrochloride production wastewater |
CN106746155A (en) * | 2015-11-19 | 2017-05-31 | 中国石油化工股份有限公司 | A kind of processing method of Lincomycin wastewater |
CN106746159A (en) * | 2015-11-19 | 2017-05-31 | 中国石油化工股份有限公司 | A kind of processing method of antibiotic production wastewater |
-
2017
- 2017-12-28 CN CN201711460314.XA patent/CN108059308B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102351377A (en) * | 2011-07-08 | 2012-02-15 | 郑州大学 | Integrated treatment method for fermentation pharmaceutical wastewater |
CN102826710A (en) * | 2012-08-17 | 2012-12-19 | 北京交通大学 | Treatment process and treatment device of high-salinity high-ammonia nitrogen pharmaceutical sewage |
CN104556528A (en) * | 2013-10-11 | 2015-04-29 | 郑州大学 | An integrated treatment process of clindamycin alkaline wastewater |
CN105036486A (en) * | 2015-08-17 | 2015-11-11 | 台州学院 | Method for deeply treating antibiotic pharmaceutical wastewater based on magnetic Fenton-like resin |
CN106746155A (en) * | 2015-11-19 | 2017-05-31 | 中国石油化工股份有限公司 | A kind of processing method of Lincomycin wastewater |
CN106746159A (en) * | 2015-11-19 | 2017-05-31 | 中国石油化工股份有限公司 | A kind of processing method of antibiotic production wastewater |
CN105417888A (en) * | 2015-12-18 | 2016-03-23 | 郑州大学综合设计研究院有限公司 | Clindamycin hydrochloride waste water processing technology |
CN106348545A (en) * | 2016-11-08 | 2017-01-25 | 河南君和环保科技有限公司 | Integrated treatment process for clindamycin hydrochloride production wastewater |
Non-Patent Citations (5)
Title |
---|
周霞等: "《水污染控制技术》", 30 April 2014, 广东高等教育出版社 * |
哈尔滨建筑工程学院: "《排水工程下册(第2版)》", 31 July 1987, 中国建筑工业出版社 * |
王娟: "《环境工程实验技术与应用》", 31 August 2016, 中国建材工业出版社 * |
罗国维等: ""投菌生物接触氧化法处理洁霉素废水的机理研究"", 《环境科学》 * |
赵艳锋等: ""高浓度制药废水处理实例"", 《水处理技术》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109534477A (en) * | 2018-11-30 | 2019-03-29 | 华南师范大学 | A kind of biodegrading process of lincomycin |
CN109534477B (en) * | 2018-11-30 | 2021-11-19 | 华南师范大学 | Method for degrading lincomycin |
Also Published As
Publication number | Publication date |
---|---|
CN108059308B (en) | 2021-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106630310B (en) | A kind of cities and towns black and odorous water processing method | |
CN106800356A (en) | A kind of advanced treatment of wastewater regeneration device based on biochemical and electrolysis tech | |
CN204529521U (en) | A kind of multimedium superposition tripping device | |
CN104445706A (en) | Method for concentrating high-concentration brine | |
CN104291522A (en) | Method for treating industrial wastewater | |
CN207062081U (en) | A kind of pharmaceutical wastewater processing system | |
CN103979750A (en) | Reactor for sewage treatment and phosphorus recovery and method for recovering phosphorus by using same | |
CN107055937A (en) | A kind of advanced treatment of wastewater regeneration method based on biochemical and electrolysis tech | |
CN106242191B (en) | A kind for the treatment of process of Pb-Zn deposits beneficiation wastewater | |
CN104118973A (en) | Technique for processing reverse osmosis concentrated water | |
CN105800872A (en) | Treatment process for diseased and dead domestic animal processing waste water | |
CN101973669A (en) | Electric power storage (EPS) waste water treatment technique | |
CN105198175A (en) | Treatment method of dimethoate pesticide production wastewater | |
CN204474506U (en) | A kind of livestock breeding wastewater treatment unit | |
JPH03293090A (en) | Method for purifying lake or marsh water and boat for purifying dirty water | |
CN108059308A (en) | A kind of clindamycin wastewater preprocessing process | |
CN105923911A (en) | Refuse leachate pretreatment method | |
CN107963761A (en) | A kind of Zero discharging system and method for high salt cyanide wastewater | |
CN109485189A (en) | Ca in high concentration chaff interferent waste water2+And SO42-Intermediate processing | |
CN103896457A (en) | Fine chemical wastewater treatment process | |
CN106044997A (en) | Treatment method of heavy metal wastewater containing Fe<3+> | |
CN104556552B (en) | Rubber accelerant wastewater treatment process | |
CN104529052B (en) | Tyre production enterprise method of wastewater treatment | |
CN106242113A (en) | A kind of comprehensive processing method of black and odorous water | |
CN109896706A (en) | A kind of sewage water advanced treatment apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |